Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Intra-carotid arterial transfusion of circulatory-derived autologous endothelial progenitor cells in rodent after ischemic stroke—evaluating the impact of therapeutic time points on prognostic outcomes

Fig. 3

Protein expressions of angiogenesis biomarkers in brain infarct zone by day 60 after acute IS. a Protein expression of CD31, *P < 0.05, ***P < 0.001, ****P < 0.0001 vs. IS. b Protein expression of von Willebrand factor (vWF), *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 vs. IS. c Protein expression of vascular endothelial growth factor (VEGF), *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 vs. IS. d Protein expression of CXCR4, **P < 0.01, ***P < 0.001, ****P < 0.0001 vs. IS. e Protein expression of stromal cell-derived growth factor (SDF)-1α, **P < 0.01, ***P < 0.001, ****P < 0.0001 vs. IS. All statistical analyses were performed by one-way ANOVA, followed by Bonferroni multiple-comparison post hoc test (n = 6 for each group). LCCA = left common carotid artery. SC = sham-operated control; IS = ischemic stroke (IS); EPC3h = EPC administration from LCCA at 3 h after acute IS; EPC3d = EPC administration from LCCA at day 3 after acute IS; EPC7d = EPC administration from LCCA at day 7 after acute IS; EPC14d = EPC administration from LCCA at day 14 after acute IS; EPC28d = EPC administration from LCCA at day 28 after acute IS

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512